NIAMS to Fund Small Business Grants for Multiplex Assay Projects | GenomeWeb

NEW YORK (GenomeWeb News) – The National Institute of Arthritis and Musculoskeletal and Skin Diseases aims to fund small businesses developing new multiplex diagnostic technologies that target biomarkers for a range of diseases.

NIAMS plans to provide Small Business Innovation Research grants of $150,000 for phase I projects and $1 million for phase II efforts to businesses developing multiplex tools for measuring multiple protein, DNA, or RNA-based biomarkers that can be detected in small volumes of fluid or biopsies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.